Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.79 | 2.2 |
NAV | ₹357.00 | ₹101.59 |
Fund Started | 17 May 2004 | 25 Mar 1997 |
Fund Size | ₹8639.72 Cr | ₹1072.74 Cr |
Exit Load | For units more than 12% of the investments, an exit load of 1% if redeemed within 12 months. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 23.78% | 26.35% |
3 Year | 21.51% | 25.37% |
5 Year | 20.63% | 24.68% |
1 Year
3 Year
5 Year
Equity | 90.14% | 99.31% |
Cash | 9.86% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 8.23% |
Bharat Petroleum Corporation Ltd. | 4.38% |
Wipro Ltd. | 3.97% |
Coal India Ltd. | 3.90% |
Radico Khaitan Ltd. | 3.75% |
ITC Ltd. | 3.48% |
ICICI Bank Ltd. | 3.46% |
NTPC Ltd. | 3.16% |
UTI Asset Management Company Ltd. | 3.09% |
Dr. Reddy's Laboratories Ltd. | 3.07% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Amey Sathe | Satish Ramanathan |
Start Date | 05 Apr 2023 | 01 Oct 2024 |
Name
Start Date
Description | The fund seeks to provide capital appreciation by investing 70 per cent of the total assets in stocks having a trailing P/E ratio less than that of the BSE Sensex at the time of investment. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 17 May 2004 | 25 Mar 1997 |
Description
Launch Date